trending Market Intelligence /marketintelligence/en/news-insights/trending/gvkRMv8bdLzzZIGdY5gXgw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Emergent BioSolutions CEO to retire; replacement named

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Emergent BioSolutions CEO to retire; replacement named

Emergent BioSolutions Inc. said Daniel Abdun-Nabi is retiring as the company's CEO and board member.

Abdun-Nabi has been the company's CEO since April 2012.

Robert Kramer, the company's current president and COO, will replace Abdun-Nabi. Effective April 1, Kramer will assume the president and CEO roles. He will also assume Abdun-Nabi's board seat.

Gaithersburg, Md.-based Emergent BioSolutions is a life sciences company developing specialty products to address public health threats.